239 related articles for article (PubMed ID: 15782133)
1. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
Vellon L; Menendez JA; Lupu R
Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
[TBL] [Abstract][Full Text] [Related]
2. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
[TBL] [Abstract][Full Text] [Related]
3. A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
Vellon L; Menendez JA; Lupu R
Mol Carcinog; 2006 Oct; 45(10):795-804. PubMed ID: 16705745
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
Vellon L; Menendez JA; Liu H; Lupu R
Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
Tsai MS; Hornby AE; Lakins J; Lupu R
Cancer Res; 2000 Oct; 60(20):5603-7. PubMed ID: 11059746
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.
Leu SJ; Lam SC; Lau LF
J Biol Chem; 2002 Nov; 277(48):46248-55. PubMed ID: 12364323
[TBL] [Abstract][Full Text] [Related]
8. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
[TBL] [Abstract][Full Text] [Related]
9. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
[TBL] [Abstract][Full Text] [Related]
10. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
11. The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
Menéndez JA; Mehmi I; Griggs DW; Lupu R
Endocr Relat Cancer; 2003 Jun; 10(2):141-52. PubMed ID: 12790776
[TBL] [Abstract][Full Text] [Related]
12. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
Miralem T; Avraham HK
Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
[TBL] [Abstract][Full Text] [Related]
15. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
16. Expression of heregulin in human coronary atherosclerotic lesions.
Panutsopulos D; Arvanitis DL; Tsatsanis C; Papalambros E; Sigala F; Spandidos DA
J Vasc Res; 2005; 42(6):463-74. PubMed ID: 16155362
[TBL] [Abstract][Full Text] [Related]
17. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
Fukui F; Hayashi SI; Yamaguchi Y
J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
[TBL] [Abstract][Full Text] [Related]
18. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.
Tong X; O'Kelly J; Xie D; Mori A; Lemp N; McKenna R; Miller CW; Koeffler HP
Oncogene; 2004 Jun; 23(28):4847-55. PubMed ID: 15077166
[TBL] [Abstract][Full Text] [Related]
19. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
20. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]